Leveraging a Franchise of AI & Business Intelligence Tools for Accelerated & Efficient Drug Development

• Contextualizing the mismatch between discovery, preclinical, and translational research in drug development and the lack of reliable AI and business intelligence solutions for these domains
• Laying out Hanmi Pharm’s expertise in peptide drug design, biomarker-driven indication prioritization, and animal-to-human translational research
• Assessing the current impact and future potential of AI/BI-driven productivity enhancement across discovery, preclinical and translational research

Speakers:

Haemin Chon

Vice President & Head, Convergence R&D Center

Hanmi Pharm